Allergy Eye Drop Market Size, Share, and Analysis, By Drug Class (Vasoconstrictors, Antihistamines, Non-steroidal Anti-Inflammatory Drugs, and Others), By Type (Vernal Keratoconjunctivitis, Seasonal and Perennial Allergic Conjunctivitis, Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis, and Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
Allergy Eye Drop Market Size, Share, and Analysis, By Drug Class (Vasoconstrictors, Antihistamines, Non-steroidal Anti-Inflammatory Drugs, and Others), By Type (Vernal Keratoconjunctivitis, Seasonal and Perennial Allergic Conjunctivitis, Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis, and Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
PRODUCT OVERVIEW
Allergy Eye Drop Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 1.2 billion and is projected to reach USD 2.2 billion by the completion of 2034.
Allergy eye drops are special liquid solutions that are applied onto the eye surface in small quantities to help relieve symptoms of eye allergies. These allergies are caused by dust, mold, pet hair, and pollens present around a person. Eye drops contain antihistamines and lubricants, which help prevent the body from producing histaminergic reactions that might cause allergies. In addition, antihistamine eye drops work by blocking histamine, which causes itching and swelling, whereas mast cell stabilizers prevent histamine from being released. Blend drops provide quick and long-lasting relief, while different allergy eye drops are used to treat eye inflammation and redness. These droplets offer precise relief with few adverse reactions and are available for purchase without a prescription.
MARKET HIGHLIGHTS
Allergy eye drop market is expected to reach USD 2.2 billion during the forecast period, owing to the rising cases of allergies across the globe and innovations in pharmaceutical formulations. In addition, a high number of consumers are seeking effective relief from symptoms caused by allergens like pollen and dust, as a result, there will be an increase in the demand for allergy eye drops. Moreover, the industry will grow as there are over-the-counter and prescription medications available for various levels of allergy severity. Furthermore, to address consumer demands, some eye drop products are now using natural and organic ingredients, which has resulted in higher product acceptance.
Allergy Eye Drop Market Segments:
Growth Drivers
Increasing Prevalence of Allergies is Critical to Boost the Adoption of Allergy Eye Drop
Availability of Advanced Formulations Will Aid the Market
Restraint
Side Effects Associated with Long-term Use Can Limit the Growth of the Allergy Eye Drop Market
Key Players
PRODUCT OVERVIEW
Allergy Eye Drop Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 1.2 billion and is projected to reach USD 2.2 billion by the completion of 2034.
Allergy eye drops are special liquid solutions that are applied onto the eye surface in small quantities to help relieve symptoms of eye allergies. These allergies are caused by dust, mold, pet hair, and pollens present around a person. Eye drops contain antihistamines and lubricants, which help prevent the body from producing histaminergic reactions that might cause allergies. In addition, antihistamine eye drops work by blocking histamine, which causes itching and swelling, whereas mast cell stabilizers prevent histamine from being released. Blend drops provide quick and long-lasting relief, while different allergy eye drops are used to treat eye inflammation and redness. These droplets offer precise relief with few adverse reactions and are available for purchase without a prescription.
MARKET HIGHLIGHTS
Allergy eye drop market is expected to reach USD 2.2 billion during the forecast period, owing to the rising cases of allergies across the globe and innovations in pharmaceutical formulations. In addition, a high number of consumers are seeking effective relief from symptoms caused by allergens like pollen and dust, as a result, there will be an increase in the demand for allergy eye drops. Moreover, the industry will grow as there are over-the-counter and prescription medications available for various levels of allergy severity. Furthermore, to address consumer demands, some eye drop products are now using natural and organic ingredients, which has resulted in higher product acceptance.
Allergy Eye Drop Market Segments:
- By Drug Class
- Vasoconstrictors
- Antihistamines
- Non-steroidal Anti-Inflammatory Drugs
- Others
- By Type
- Vernal Keratoconjunctivitis
- Seasonal and Perennial Allergic Conjunctivitis
- Atopic Keratoconjunctivitis
- Giant Papillary Conjunctivitis
- Others
- By Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
Growth Drivers
Increasing Prevalence of Allergies is Critical to Boost the Adoption of Allergy Eye Drop
Availability of Advanced Formulations Will Aid the Market
Restraint
Side Effects Associated with Long-term Use Can Limit the Growth of the Allergy Eye Drop Market
Key Players
- Allergan
- Similasan Corporation
- Prestige Consumer Healthcare Inc.
- Bausch & Lomb
- Akorn, Inc.
- Rohto Pharmaceutical Co., Ltd.
- Novartis AG (Alcon)
- Johnson & Johnson Vision
- Sun Pharmaceutical Industries Ltd.
- Santen Pharmaceutical Co., Ltd.
- Eyevance Pharmaceuticals LLC
- Scope Ophthalmics Ltd.
- Pfizer Inc.
- Optrex
- Apotex Inc.
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3.Allergy Eye Drop Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Allergy Eye Drop Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. ALLERGY EYE DROP MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. ALLERGY EYE DROP MARKET
10.1.Overview
10.2. Historical Analysis (2018-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Drug Class
11.3.1.1. Vasoconstrictors
11.3.1.1.1. By Value (USD Million) 2024A-2034F
11.3.1.1.2.Market Share (%) 2024A-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.2.Antihistamines
11.3.1.2.1.By Value (USD Million) 2024A-2034F
11.3.1.2.2. Market Share (%) 2024A-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.3.Non-steroidal Anti-Inflammatory Drugs
11.3.1.3.1.By Value (USD Million) 2024A-2034F
11.3.1.3.2. Market Share (%) 2024A-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.4.Others
11.3.1.4.1.By Value (USD Million) 2024A-2034F
11.3.1.4.2. Market Share (%) 2024A-2034F
11.3.1.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2. By Type
11.3.2.1.Vernal Keratoconjunctivitis
11.3.2.1.1.By Value (USD Million) 2024A-2034F
11.3.2.1.2. Market Share (%) 2024A-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.2. Seasonal and Perennial Allergic Conjunctivitis
11.3.2.2.1. By Value (USD Million) 2024A-2034F
11.3.2.2.2.Market Share (%) 2024A-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.3. Atopic Keratoconjunctivitis
11.3.2.3.1. By Value (USD Million) 2024A-2034F
11.3.2.3.2.Market Share (%) 2024A-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.4. Giant Papillary Conjunctivitis
11.3.2.4.1. By Value (USD Million) 2024A-2034F
11.3.2.4.2.Market Share (%) 2024A-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2024A-2034F
11.3.2.5.2.Market Share (%) 2024A-2034F
11.3.2.5.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3. By Distribution Channel
11.3.3.1.Online Pharmacies
11.3.3.1.1.By Value (USD Million) 2024A-2034F
11.3.3.1.2. Market Share (%) 2024A-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.2. Retail Pharmacies
11.3.3.2.1. By Value (USD Million) 2024A-2034F
11.3.3.2.2.Market Share (%) 2024A-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3.3. Hospital Pharmacies
11.3.3.3.1. By Value (USD Million) 2024A-2034F
11.3.3.3.2.Market Share (%) 2024A-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024A-2034F
12. NORTH AMERICA ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Drug Class
12.3.2.By Type
12.3.3.By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2.Canada
13. EUROPE ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Drug Class
13.3.2.By Type
13.3.3.By Distribution Channel
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Drug Class
14.3.2.By Type
14.3.3.By Distribution Channel
14.4.Country
14.4.1.India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Drug Class
15.3.2.By Type
15.3.3.By Distribution Channel
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Drug Class
16.3.2.By Type
16.3.3.By Distribution Channel
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Allergan
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.2.Similasan Corporation
18.3.Prestige Consumer Healthcare Inc.
18.4. Bausch & Lomb
18.5.Akorn, Inc.
18.6.Rohto Pharmaceutical Co., Ltd.
18.7.Novartis AG (Alcon)
18.8. Johnson & Johnson Vision
18.9.Sun Pharmaceutical Industries Ltd.
18.10.Santen Pharmaceutical Co., Ltd.
18.11. Eyevance Pharmaceuticals LLC
18.12. Scope Ophthalmics Ltd.
18.13. Pfizer Inc.
18.14.Apotex Inc
18.15. Optrex
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3.Allergy Eye Drop Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Allergy Eye Drop Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. ALLERGY EYE DROP MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. ALLERGY EYE DROP MARKET
10.1.Overview
10.2. Historical Analysis (2018-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Drug Class
11.3.1.1. Vasoconstrictors
11.3.1.1.1. By Value (USD Million) 2024A-2034F
11.3.1.1.2.Market Share (%) 2024A-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.2.Antihistamines
11.3.1.2.1.By Value (USD Million) 2024A-2034F
11.3.1.2.2. Market Share (%) 2024A-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.3.Non-steroidal Anti-Inflammatory Drugs
11.3.1.3.1.By Value (USD Million) 2024A-2034F
11.3.1.3.2. Market Share (%) 2024A-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.4.Others
11.3.1.4.1.By Value (USD Million) 2024A-2034F
11.3.1.4.2. Market Share (%) 2024A-2034F
11.3.1.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2. By Type
11.3.2.1.Vernal Keratoconjunctivitis
11.3.2.1.1.By Value (USD Million) 2024A-2034F
11.3.2.1.2. Market Share (%) 2024A-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.2. Seasonal and Perennial Allergic Conjunctivitis
11.3.2.2.1. By Value (USD Million) 2024A-2034F
11.3.2.2.2.Market Share (%) 2024A-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.3. Atopic Keratoconjunctivitis
11.3.2.3.1. By Value (USD Million) 2024A-2034F
11.3.2.3.2.Market Share (%) 2024A-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.4. Giant Papillary Conjunctivitis
11.3.2.4.1. By Value (USD Million) 2024A-2034F
11.3.2.4.2.Market Share (%) 2024A-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2024A-2034F
11.3.2.5.2.Market Share (%) 2024A-2034F
11.3.2.5.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3. By Distribution Channel
11.3.3.1.Online Pharmacies
11.3.3.1.1.By Value (USD Million) 2024A-2034F
11.3.3.1.2. Market Share (%) 2024A-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.2. Retail Pharmacies
11.3.3.2.1. By Value (USD Million) 2024A-2034F
11.3.3.2.2.Market Share (%) 2024A-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3.3. Hospital Pharmacies
11.3.3.3.1. By Value (USD Million) 2024A-2034F
11.3.3.3.2.Market Share (%) 2024A-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024A-2034F
12. NORTH AMERICA ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Drug Class
12.3.2.By Type
12.3.3.By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2.Canada
13. EUROPE ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Drug Class
13.3.2.By Type
13.3.3.By Distribution Channel
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Drug Class
14.3.2.By Type
14.3.3.By Distribution Channel
14.4.Country
14.4.1.India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Drug Class
15.3.2.By Type
15.3.3.By Distribution Channel
15.4. Country
15.4.1.Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA ALLERGY EYE DROP MARKET SIZE & FORECAST 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Drug Class
16.3.2.By Type
16.3.3.By Distribution Channel
16.4. Country
16.4.1.Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Allergan
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.2.Similasan Corporation
18.3.Prestige Consumer Healthcare Inc.
18.4. Bausch & Lomb
18.5.Akorn, Inc.
18.6.Rohto Pharmaceutical Co., Ltd.
18.7.Novartis AG (Alcon)
18.8. Johnson & Johnson Vision
18.9.Sun Pharmaceutical Industries Ltd.
18.10.Santen Pharmaceutical Co., Ltd.
18.11. Eyevance Pharmaceuticals LLC
18.12. Scope Ophthalmics Ltd.
18.13. Pfizer Inc.
18.14.Apotex Inc
18.15. Optrex
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
